Connecticut Seal

Substitute Senate Bill No. 28

Public Act No. 15-219

AN ACT CONCERNING MANUFACTURER NAMES, MEDWATCH REPORTING INFORMATION AND BRAND NAMES ON GENERIC DRUG CONTAINERS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. Section 20-617 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2016):

(a) Each pharmacist shall include on the label of each prescription container: (1) The quantity of prescribed drug placed in such container, in addition to any other information required by law, [; ] and (2) a prominently printed expiration date based on the manufacturer's recommended conditions of use and storage that can be read and understood by the ordinary individual. The expiration date required pursuant to subdivision (2) of this [section] subsection shall be no later than the expiration date determined by the manufacturer.

(b) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (c) of this section, each pharmacist shall include on the label of each prescription container or on the receipt or other similar packaging in which the prescription is contained for a drug sold only by generic name, as defined in section 20-14a, and not by brand name, as defined in said section: (1) The name of the manufacturer of the generic drug placed in the container, and (2) the Internet web site address and toll-free telephone number for the United States Food and Drug Administration's safety information and adverse event reporting program (MedWatch).

(c) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (b) of this section, if a pharmacist substitutes a generic name drug for a brand name drug, such pharmacist shall include on the label of the prescription container: (1) The name of the generic drug placed in the container, and (2) the brand name of the drug that the generic drug was substituted for.

Approved July 6, 2015